Yellow fever resurgence: An avoidable crisis?

Lindsey, Nicole P; Horton, Jennifer; Barrett, Alan D T; Demanou, Maurice; Monath, Thomas P; Tomori, Oyewale; Van Herp, Michel; Zeller, Herve; Fall, Ibrahima Soce; Cibrelus, Laurence; Erin Staples, J

Lindsey, Nicole P; Horton, Jennifer; Barrett, Alan D T; Demanou, Maurice; Monath, Thomas P; Tomori, Oyewale; Van Herp, Michel; Zeller, Herve; Fall, Ibrahima Soce; Cibrelus, Laurence; Erin Staples, J.

Lindsey NP; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland. frd3@cdc.gov.
Horton J; Arboviral Diseases Branch, U.S. Centers for Disease Control and Prevention, Fort Collins, CO, USA. frd3@cdc.gov.
Barrett ADT; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.
Demanou M; Eliminate Yellow Fever Epidemics Strategy, High Impact Epidemics, WHO Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
Monath TP; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.
Tomori O; Department of Pathology and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
Van Herp M; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.
Zeller H; Regional Office for Africa, World Health Organization, Ouagadougou, Burkina Faso.
Fall IS; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.
Cibrelus L; Crozet BioPharma, Lexington, MA, USA.
Erin Staples J; Eliminate Yellow Fever Epidemic Risk Assessment Working Group, Geneva, Switzerland.

NPJ Vaccines ; 7(1): 137, 2022 Nov 02.

Article in English | MEDLINE | ID: covidwho-2269180

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: NPJ Vaccines Year: 2022 Document Type: Article Affiliation country: S41541-022-00552-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google